Bayer Pakistan and AMAN announce collaboration on World Contr
aception Day to raise awareness about the urgent need for increasing access to modern contr
aceptive methodsApproximately 3.7 million unintended pregnancies occur annually in Pakistan1, creating a grav
e healthcare and economic burden that can be reduced through increased access to, and use of, modern contr
aceptive methods.
Lahore, September 26, 2024 – On the occasion of World Contr
aception Day 2024, Bayer Pakistan and the Association for Mothers & Newborns (AMAN) committed to a collaboration utilizing their combined expertise and knowledge to increase awareness about modern contr
aceptive methods and their safe use, for the benefit of the general population of Pakistan.
An MoU signing ceremony was held between both parties, followed by the first of multiple planned scientific sessions for doctors to be held across the country, to create awareness on how modern contr
aceptive methods can contribute to women’s wellness and child health.
(adsbygoogle = window.adsbygoogle || []).push({});
Ce
lebrated globally and supported by a coalition of international organizations including Bayer, World Contr
aception Day (WCD) focuses on the crucial role of informed decision-making
in reducing unintended pregnancies, i
n a world where many women have limited control on their reproductiv
e health.
This is especially relevant for Pakistan, where among women aged 15 to 49, approximately 19 million express a desire to avoid unintended pregnancy. However, of these, 50% (9.5 million women) do not have access to modern contr
aceptives.1
According to the Guttmacher Institute, a leading reproductiv
e health research organization, approximately 3.7 million unintended pregnancies occur annually in Pakistan, with 61% (2.2 million) resulting in induced abortions.1Unintended pregnancies take a serious toll on women’s health, often leading to unsafe medical procedures, as well as exacerbating economic challenges for families. Increasing access to modern contr
aceptives is therefore critical in mitigating both issues.
(adsbygoogle = window.adsbygoogle || []).push({});
Speaking on the occasion, Khurram Mirza, Country Commercial Lead, Pharmaceutical Division, Bayer Pakistan, said, “Our WCD collaboration with AMAN is well-aligned with Bayer’s global mission, Health for All, Hunger for None, as well as the company’s focus on women’s healthcare. Women’s health is in Bayer’s DNA; as a global leader in the segment, Bayer offers a wide range of contr
aceptive options, as well as therapies for menopause management and gynecological diseases. Additionally, Bayer intends to provide 100 million women in low-and-middle income countries with access to family planning by 2030, by funding capacity building programs and ensuring the supply of affordable modern contr
aceptives.”
Prof. Dr. Sadiah Ahsan Pal, Vice President AMAN, commented, ““Family planning is Pakistan’s number on
e health priority. The progress of our nation depends on it. Not forced but by choice. Every doctor, nurse, LHV, LHW or midwife who is delivering a healthy baby holds the key to futur
e health of that family. That family is eternally grateful and looks up to them for advice. We should counsel them properly about family planning, making informed choices to prevent unplanned pregnancy. If we do this right, we will be making a huge contribution towards th
e healthy progress of our nation.”Both Bayer Pakistan and AMAN are optimistic that this series of symposiums will catalyze a wider conversation in th
e healthcare community and beyond about the urgent need for increasing access to modern contr
aceptive methods, benefiting women and families across Pakistan.